BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 23926687)

  • 1. [Relationship between aberrant expression of miRNAs and prostate cancer].
    Zhang JY; Yang J; Song NH
    Zhonghua Nan Ke Xue; 2013 Jul; 19(7):657-61. PubMed ID: 23926687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The role of miRNAs in androgen-independent progression of prostate cancer].
    Yang J; Zhang JY; Song NH
    Zhonghua Nan Ke Xue; 2013 Sep; 19(9):831-4. PubMed ID: 24386864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs and zinc metabolism-related gene expression in prostate cancer cell lines treated with zinc(II) ions.
    Hlavna M; Raudenska M; Hudcova K; Gumulec J; Sztalmachova M; Tanhäuserova V; Babula P; Adam V; Eckschlager T; Kizek R; Masarik M
    Int J Oncol; 2012 Dec; 41(6):2237-44. PubMed ID: 23064315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [MicroRNAs and prostate cancer].
    Yang CH; Zhang CN
    Zhonghua Nan Ke Xue; 2010 Sep; 16(9):844-9. PubMed ID: 21171273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs and prostate cancer.
    Pang Y; Young CY; Yuan H
    Acta Biochim Biophys Sin (Shanghai); 2010 Jun; 42(6):363-9. PubMed ID: 20539944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The microRNA profile of prostate carcinoma obtained by deep sequencing.
    Szczyrba J; Löprich E; Wach S; Jung V; Unteregger G; Barth S; Grobholz R; Wieland W; Stöhr R; Hartmann A; Wullich B; Grässer F
    Mol Cancer Res; 2010 Apr; 8(4):529-38. PubMed ID: 20353999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic analysis of microRNAs targeting the androgen receptor in prostate cancer cells.
    Östling P; Leivonen SK; Aakula A; Kohonen P; Mäkelä R; Hagman Z; Edsjö A; Kangaspeska S; Edgren H; Nicorici D; Bjartell A; Ceder Y; Perälä M; Kallioniemi O
    Cancer Res; 2011 Mar; 71(5):1956-67. PubMed ID: 21343391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNAs in prostate cancer: from biomarkers to molecularly-based therapeutics.
    Gordanpour A; Nam RK; Sugar L; Seth A
    Prostate Cancer Prostatic Dis; 2012 Dec; 15(4):314-9. PubMed ID: 22333688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA expression profiling in prostate cancer.
    Porkka KP; Pfeiffer MJ; Waltering KK; Vessella RL; Tammela TL; Visakorpi T
    Cancer Res; 2007 Jul; 67(13):6130-5. PubMed ID: 17616669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of expression profiling of circulating microRNAs in men with prostate cancer.
    Kelly BD; Miller N; Healy NA; Walsh K; Kerin MJ
    BJU Int; 2013 Jan; 111(1):17-21. PubMed ID: 22612403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [MicroRNA in prostate cancer].
    Nakagawa M
    Nihon Rinsho; 2014 Dec; 72(12):2224-8. PubMed ID: 25518362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The activity and expression of microRNAs in prostate cancers.
    Fu X; Xue C; Huang Y; Xie Y; Li Y
    Mol Biosyst; 2010 Dec; 6(12):2561-72. PubMed ID: 20957285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs and cancer.
    Cowland JB; Hother C; Grønbaek K
    APMIS; 2007 Oct; 115(10):1090-106. PubMed ID: 18042145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miRNAs differentially expressed in prostate cancer cell lines after soy treatment.
    Rabiau N; Trraf HK; Adjakly M; Bosviel R; Guy L; Fontana L; Bignon YJ; Bernard-Gallon DJ
    In Vivo; 2011; 25(6):917-21. PubMed ID: 22021684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Widespread deregulation of microRNA expression in human prostate cancer.
    Ozen M; Creighton CJ; Ozdemir M; Ittmann M
    Oncogene; 2008 Mar; 27(12):1788-93. PubMed ID: 17891175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor suppressive microRNAs (miR-222 and miR-31) regulate molecular pathways based on microRNA expression signature in prostate cancer.
    Fuse M; Kojima S; Enokida H; Chiyomaru T; Yoshino H; Nohata N; Kinoshita T; Sakamoto S; Naya Y; Nakagawa M; Ichikawa T; Seki N
    J Hum Genet; 2012 Nov; 57(11):691-9. PubMed ID: 22854542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging role of microRNAs in prostate cancer: implications for personalized medicine.
    Gandellini P; Folini M; Zaffaroni N
    Discov Med; 2010 Mar; 9(46):212-8. PubMed ID: 20350487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiRNA targets of prostate cancer.
    Deng JH; Deng Q; Kuo CH; Delaney SW; Ying SY
    Methods Mol Biol; 2013; 936():357-69. PubMed ID: 23007521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA involvement in the pathogenesis and management of breast cancer.
    Khoshnaw SM; Green AR; Powe DG; Ellis IO
    J Clin Pathol; 2009 May; 62(5):422-8. PubMed ID: 19398594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Livin expression may be regulated by miR-198 in human prostate cancer cell lines.
    Ye L; Li S; Ye D; Yang D; Yue F; Guo Y; Chen X; Chen F; Zhang J; Song X
    Eur J Cancer; 2013 Feb; 49(3):734-40. PubMed ID: 23069480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.